Compare RBBN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBBN | FLGT |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.4M | 525.3M |
| IPO Year | 2017 | 2016 |
| Metric | RBBN | FLGT |
|---|---|---|
| Price | $2.62 | $15.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.67 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 1.0M | 400.2K |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.97 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | N/A | ★ $18,730,000.00 |
| Revenue This Year | $1.97 | $10.09 |
| Revenue Next Year | $6.69 | $12.18 |
| P/E Ratio | $10.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.83 | $13.46 |
| 52 Week High | $4.29 | $31.04 |
| Indicator | RBBN | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 41.63 |
| Support Level | $2.05 | $14.23 |
| Resistance Level | $2.93 | $16.76 |
| Average True Range (ATR) | 0.17 | 0.57 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 41.67 | 37.09 |
Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.